{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T02:28:49Z","timestamp":1772850529773,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>P21-activated kinases (PAKs) are serine\/threonine protein kinase which have six different isoforms (PAK1\u20136). Of those, PAK1 is overexpressed in many cancers and considered to be a major chemotherapeutic target. Most of the developed PAK1 inhibitor drugs work as pan-PAK inhibitors and show undesirable toxicity due to having untargeted kinase inhibition activities. Selective PAK1 inhibitors are therefore highly desired and oncogenic drug hunters are trying to develop allosteric PAK1 inhibitors. We previously synthesized 1,2,3-triazolyl ester of ketorolac (15K) through click chemistry technique, which exhibits significant anti-cancer effects via inhibiting PAK1. Based on the selective anticancer effects of 15K against PAK1-dependent cancer cells, we hypothesize that it may act as an allosteric PAK1 inhibitor. In this study, computational analysis was done with 15K to explore its quantum chemical and thermodynamic properties, molecular interactions and binding stability with PAK1, physicochemical properties, ADMET, bioactivities, and druglikeness features. Molecular docking analysis demonstrates 15K as a potent allosteric ligand that strongly binds to a novel allosteric site of PAK1 (binding energy ranges \u2013\u00a08.6 to \u2013\u00a09.2\u00a0kcal\/mol) and does not target other PAK isoforms; even 15K shows better interactions than another synthesized PAK1 inhibitor. Molecular dynamics simulation clearly supports the stable binding properties of 15K with PAK1 crystal. Density functional theory-based calculations reveal that it can be an active drug with high softness and moderate polarity, and ADMET predictions categorize it as a non-toxic drug as evidenced by in vitro studies with brine shrimp and fibroblast cells. Structure\u2013activity relationship clarifies the role of ester bond and triazol moiety of 15K\u00a0in establishing novel allosteric interactions. Our results summarize that 15K selectively inhibits PAK1\u00a0as an allosteric inhibitor and in turn shows anticancer effects without toxicity.<\/jats:p>","DOI":"10.1038\/s41598-021-96817-3","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T10:04:51Z","timestamp":1630490691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Molecular modelling approaches predicted 1,2,3-triazolyl ester of ketorolac (15K) to be a novel allosteric modulator of the oncogenic kinase PAK1"],"prefix":"10.1038","volume":"11","author":[{"given":"Md","family":"Shahinozzaman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinthyia","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashiduzzaman","family":"Emran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinkichi","family":"Tawata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"key":"96817_CR1","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1042\/BC20070109","volume":"100","author":"LE Arias-Romero","year":"2008","unstructured":"Arias-Romero, L. E. & Chernoff, J. A tale of two Paks. Biol. Cell 100, 97\u2013108 (2008).","journal-title":"Biol. Cell"},{"key":"96817_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0204-0","volume":"51","author":"SY Won","year":"2019","unstructured":"Won, S. Y., Park, J. J., Shin, E. Y. & Kim, E. G. PAK4 signaling in health and disease: defining the PAK4\u2013CREB axis. Exp. Mol. 51, 1\u20139 (2019).","journal-title":"Exp. Mol."},{"key":"96817_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrc3645","volume":"14","author":"M Radu","year":"2014","unstructured":"Radu, M., Semenova, G., Kosoff, R. & Chernoff, J. PAK signalling during the development and progression of cancer. Nat. Rev. Cancer. 14, 13\u201325 (2014).","journal-title":"Nat. Rev. Cancer."},{"key":"96817_CR4","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejcb.2013.03.002","volume":"92","author":"AE Dart","year":"2013","unstructured":"Dart, A. E. & Wells, C. M. P21-activated kinase 4: Not just one of the PAK. Eur. J. Cell Biol. 92, 129\u2013138 (2013).","journal-title":"Eur. J. Cell Biol."},{"key":"96817_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4161\/cl.21882","volume":"2","author":"DZ Ye","year":"2012","unstructured":"Ye, D. Z. & Field, J. PAK signaling in cancer. Cell. Logist. 2, 105\u2013116 (2012).","journal-title":"Cell. Logist."},{"key":"96817_CR6","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ptr.5054","volume":"28","author":"H Maruta","year":"2014","unstructured":"Maruta, H. Herbal therapeutics that block the oncogenic kinase PAK1: A practical approach towards PAK1-dependent diseases and longevity. Phytother. Res. 28, 656\u2013672 (2014).","journal-title":"Phytother. Res."},{"key":"96817_CR7","doi-asserted-by":"publisher","first-page":"7122","DOI":"10.1128\/MCB.23.20.7122-7133.2003","volume":"23","author":"J Qu","year":"2003","unstructured":"Qu, J. et al. PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol. Cell. Biol. 23, 7122\u20137133 (2003).","journal-title":"Mol. Cell. Biol."},{"key":"96817_CR8","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/0192623311432289","volume":"40","author":"A John-Baptiste","year":"2012","unstructured":"John-Baptiste, A. et al. Evaluation of potential gastrointestinal biomarkers in a PAK4 inhibitor-treated preclinical toxicity model to address unmonitorable gastrointestinal toxicity. Toxicol. Pathol. 40, 482\u2013490 (2012).","journal-title":"Toxicol. Pathol."},{"key":"96817_CR9","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.ejmech.2016.11.038","volume":"126","author":"BCQ Nguyen","year":"2017","unstructured":"Nguyen, B. C. Q. et al. 1, 2, 3-triazolyl ester of ketorolac: A \u201cclick chemistry\u201d-based highly potent PAK1-blocking cancer-killer. Eur. J. Med. Chem. 126, 270\u2013276 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"96817_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","volume":"71","author":"D Dheer","year":"2017","unstructured":"Dheer, D., Singh, V. & Shankar, R. Medicinal attributes of 1, 2, 3-triazoles: Current developments. Bioorg. Chem. 71, 30\u201354 (2017).","journal-title":"Bioorg. Chem."},{"key":"96817_CR11","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1359-6446(03)02933-7","volume":"8","author":"HC Kolb","year":"2003","unstructured":"Kolb, H. C. & Sharpless, K. B. The growing impact of click chemistry on drug discovery. Drug. Discov. Today 8, 1128\u20131137 (2003).","journal-title":"Drug. Discov. Today"},{"key":"96817_CR12","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5582\/ddt.2018.01018","volume":"12","author":"BCQ Nguyen","year":"2018","unstructured":"Nguyen, B. C. Q. et al. 1, 2, 3-Triazolyl ester of ketorolac (15K): Boosting both heat-endurance and lifespan of C. elegans by down-regulating PAK1 at nM levels. Drug Discov. Ther. 12, 92\u201396 (2018).","journal-title":"Drug Discov. Ther."},{"key":"96817_CR13","doi-asserted-by":"publisher","first-page":"300","DOI":"10.5582\/ddt.2017.01058","volume":"11","author":"MR Ahn","year":"2017","unstructured":"Ahn, M. R. et al. Both triazolyl ester of ketorolac (15K) and YM155 inhibit the embryonic angiogenesis in ovo (fertilized eggs) via their common PAK1-survivin\/VEGF signaling pathway. Drug. Discov. Ther. 11, 300\u2013306 (2017).","journal-title":"Drug. Discov. Ther."},{"key":"96817_CR14","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1021\/acsmedchemlett.5b00102","volume":"6","author":"AS Karpov","year":"2015","unstructured":"Karpov, A. S. et al. Optimization of a dibenzodiazepine hit to a potent and selective allosteric PAK1 inhibitor. ACS Med. Chem. Lett. 6, 776\u2013781 (2015).","journal-title":"ACS Med. Chem. Lett."},{"key":"96817_CR15","first-page":"200","volume-title":"Gaussian 09, Revision A 0.2","author":"MJ Frisch","year":"2009","unstructured":"Frisch, M. J. et al. Gaussian 09, Revision A 0.2 200 (Gaussian Inc, 2009)."},{"key":"96817_CR16","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1002\/jcc.20823","volume":"29","author":"NM O\u2019boyle","year":"2008","unstructured":"O\u2019boyle, N. M., Tenderholt, A. L. & Langner, K. M. Cclib: A library for package-independent computational chemistry algorithms. J. Comput. Chem. 29, 839\u2013845 (2008).","journal-title":"J. Comput. Chem."},{"key":"96817_CR17","doi-asserted-by":"publisher","first-page":"8440","DOI":"10.1073\/pnas.83.22.8440","volume":"83","author":"RG Pearson","year":"1986","unstructured":"Pearson, R. G. Absolute electronegativity and hardness correlated with molecular orbital theory. Proc. Natl. Acad. Sci. USA. 83, 8440 (1986).","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"96817_CR18","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"C Lee","year":"1988","unstructured":"Lee, C., Yang, W. & Parr, R. G. Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys. Rev. B 37, 785\u2013789 (1988).","journal-title":"Phys. Rev. B"},{"key":"96817_CR19","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott, O. & Olson, A. J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455\u2013461 (2010).","journal-title":"J. Comput. Chem."},{"key":"96817_CR20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/scipharm86030032","volume":"86","author":"M Shahinozzaman","year":"2018","unstructured":"Shahinozzaman, M. et al. Cytotoxic desulfated saponin from Holothuria atra predicted to have high binding affinity to the oncogenic kinase PAK1: A combined in vitro and in silico study. Sci. Pharm. 86, 32 (2018).","journal-title":"Sci. Pharm."},{"key":"96817_CR21","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1080\/07391102.2019.1659855","volume":"38","author":"M Shahinozzaman","year":"2020","unstructured":"Shahinozzaman, M., Ishii, T., Ahmed, S., Halim, M. A. & Tawata, S. A computational approach to explore and identify potential herbal inhibitors for the p21-activated kinase 1 (PAK1). J. Biomol. Struct. Dyn. 38, 3514\u20133526 (2020).","journal-title":"J. Biomol. Struct. Dyn."},{"key":"96817_CR22","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1002\/prot.20251","volume":"57","author":"E Krieger","year":"2004","unstructured":"Krieger, E., Darden, T., Nabuurs, S. B., Finkelstein, A. & Vriend, G. Making optimal use of empirical energy functions: Force-field parameterization in crystal space. Proteins 57, 678\u2013683 (2004).","journal-title":"Proteins"},{"key":"96817_CR23","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/cem.1180040607","volume":"4","author":"S De Jong","year":"1990","unstructured":"De Jong, S. Multivariate calibration. J. Chemom. 4, 441\u2013441. https:\/\/doi.org\/10.1002\/cem.1180040607 (1990).","journal-title":"J. Chemom."},{"key":"96817_CR24","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0169-7439(87)80084-9","volume":"2","author":"S Wold","year":"1987","unstructured":"Wold, S., Esbensen, K. & Geladi, P. Principal component analysis. Chemom. Intell. Lab. Syst. 2, 37\u201352. https:\/\/doi.org\/10.1016\/0169-7439(87)80084-9 (1987).","journal-title":"Chemom. Intell. Lab. Syst."},{"key":"96817_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-98141-3","volume-title":"ggplot2: Elegant Graphics for Data Analysis","author":"H Wickham","year":"2009","unstructured":"Wickham, H. ggplot2: Elegant Graphics for Data Analysis (Springer, 2009). https:\/\/doi.org\/10.1007\/978-0-387-98141-3."},{"key":"96817_CR26","doi-asserted-by":"publisher","first-page":"4066","DOI":"10.1021\/acs.jmedchem.5b00104","volume":"55","author":"DE Pires","year":"2015","unstructured":"Pires, D. E., Blundell, T. L. & Ascher, D. B. pkCSM: Predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 55, 4066\u20134072 (2015).","journal-title":"J. Med. Chem."},{"key":"96817_CR27","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","volume":"50","author":"DA Filimonov","year":"2014","unstructured":"Filimonov, D. A. et al. Prediction of the biological activity spectra of organic compounds using the PASS online web resource. Chem. Heterocycl. Compd. 50, 444\u2013457 (2014).","journal-title":"Chem. Heterocycl. Compd."},{"key":"96817_CR28","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.ijmyco.2016.06.020","volume":"5","author":"PG Jamkhande","year":"2016","unstructured":"Jamkhande, P. G., Pathan, S. K. & Wadher, S. J. In silico PASS analysis and determination of antimycobacterial, antifungal, and antioxidant efficacies of maslinic acid in an extract rich in pentacyclic triterpenoids. Int. J. Mycobacteriol. 5, 417\u2013425 (2016).","journal-title":"Int. J. Mycobacteriol."},{"key":"96817_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep42717","volume":"7","author":"A Daina","year":"2017","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 1\u20133 (2017).","journal-title":"Sci. Rep."},{"key":"96817_CR30","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.3390\/molecules23102479","volume":"23","author":"M Shahinozzaman","year":"2018","unstructured":"Shahinozzaman, M. et al. Anti-inflammatory, anti-diabetic, and anti-alzheimer\u2019s effects of prenylated flavonoids from Okinawa propolis: An investigation by experimental and computational studies. Molecules 23, 2479 (2018).","journal-title":"Molecules"},{"key":"96817_CR31","first-page":"578","volume":"14","author":"M Shahinozzaman","year":"2018","unstructured":"Shahinozzaman, M. et al. Anti-inflammatory and anti-melanogenic effects of major leaf components of Alpinia zerumbet var. excelsa. Pharmacog. Mag. 14, 578 (2018).","journal-title":"Pharmacog. Mag."},{"key":"96817_CR32","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1134\/S0026893308040195","volume":"42","author":"MY Lobanov","year":"2008","unstructured":"Lobanov, M. Y., Bogatyreva, N. S. & Galzitskaya, O. V. Radius of gyration as an indicator of protein structure compactness. Mol. Biol. 42, 623\u2013628. https:\/\/doi.org\/10.1134\/S0026893308040195 (2008).","journal-title":"Mol. Biol."},{"key":"96817_CR33","doi-asserted-by":"publisher","first-page":"2431","DOI":"10.1093\/bioinformatics\/bts445","volume":"28","author":"E Fuglebakk","year":"2012","unstructured":"Fuglebakk, E., Echave, J. & Reuter, N. Measuring and comparing structural fluctuation patterns in large protein datasets. Bioinformatics 28, 2431\u20132440. https:\/\/doi.org\/10.1093\/bioinformatics\/bts445 (2012).","journal-title":"Bioinformatics"},{"key":"96817_CR34","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0092-8674(00)00043-X","volume":"102","author":"M Lei","year":"2000","unstructured":"Lei, M. et al. Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102, 387\u2013397. https:\/\/doi.org\/10.1016\/S0092-8674(00)00043-X (2000).","journal-title":"Cell"},{"key":"96817_CR35","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski, C. A., Lombardo, F., Dominy, B. W. & Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug. Deliv. Rev. 46, 3\u201326 (2001).","journal-title":"Adv. Drug. Deliv. Rev."},{"key":"96817_CR36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1021\/cc9800071","volume":"1","author":"AK Ghose","year":"1999","unstructured":"Ghose, A. K., Viswanadhan, V. N. & Wendoloski, J. J. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. J. Comb. Chem. 1, 55\u201368 (1999).","journal-title":"J. Comb. Chem."},{"key":"96817_CR37","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1021\/jm020017n","volume":"45","author":"DF Veber","year":"2002","unstructured":"Veber, D. F. et al. Molecular properties that influence the oral bioavailability of drug candidates. J. Med. Chem. 45, 2615\u20132623 (2002).","journal-title":"J. Med. Chem."},{"key":"96817_CR38","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1021\/jm000292e","volume":"43","author":"WJ Egan","year":"2000","unstructured":"Egan, W. J., Merz, K. M. & Baldwin, J. J. Prediction of drug absorption using multivariate statistics. J. Med. Chem. 43, 3867\u20133877 (2000).","journal-title":"J. Med. Chem."},{"key":"96817_CR39","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1021\/jm015507e","volume":"44","author":"I Muegge","year":"2001","unstructured":"Muegge, I., Heald, S. L. & Brittelli, D. Simple selection criteria for drug-like chemical matter. J. Med. Chem. 44, 1841\u20131846 (2001).","journal-title":"J. Med. Chem."},{"key":"96817_CR40","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jps.2600710611","volume":"71","author":"EJ Lien","year":"1982","unstructured":"Lien, E. J., Guo, Z. R., Li, R. L. & Su, C. T. Use of dipole moment as a parameter in drug-receptor interaction and quantitative structure-activity relationship studies. J. Pharm. Sci. 71, 641\u2013655 (1982).","journal-title":"J. Pharm. Sci."},{"key":"96817_CR41","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1002\/(SICI)1098-1128(200001)20:1<58::AID-MED3>3.0.CO;2-X","volume":"20","author":"N Bodor","year":"2000","unstructured":"Bodor, N. & Buchwald, P. Soft drug design: General principles and recent applications. Med. Res. Rev. 20, 58\u2013101 (2000).","journal-title":"Med. Res. Rev."},{"key":"96817_CR42","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1002\/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.0.CO;2-5","volume":"40","author":"HC Kolb","year":"2001","unstructured":"Kolb, H. C., Finn, M. G. & Sharpless, K. B. Click chemistry: Diverse chemical function from a few good reactions. Angew. Chem. Int. Ed. 40, 2004\u20132021 (2001).","journal-title":"Angew. Chem. Int. Ed."},{"key":"96817_CR43","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1021\/acs.jmedchem.7b00237","volume":"60","author":"P Matsson","year":"2017","unstructured":"Matsson, P. & Kihlberg, J. How big is too big for cell permeability?. J. Med. Chem. 60, 1662\u20131664 (2017).","journal-title":"J. Med. Chem."},{"key":"96817_CR44","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1038\/jcbfm.2012.126","volume":"32","author":"WM Pardridge","year":"2012","unstructured":"Pardridge, W. M. Drug transport across the blood\u2013brain barrier. J. Cereb. Blood Flow Metab. 32, 1959\u20131972 (2012).","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"96817_CR45","volume-title":"Ketorolac","author":"AN Mahmoodi","year":"2021","unstructured":"Mahmoodi, A. N. & Kim, P. Y. Ketorolac (StatPearls Publishing, 2021)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96817-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96817-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T04:11:10Z","timestamp":1699416670000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-96817-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["96817"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-96817-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"20 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17471"}}